MedPath
HSA Approval

AZMASOL HFA INHALATION AEROSOL 100MCG

SIN13980P

AZMASOL HFA INHALATION AEROSOL 100MCG

AZMASOL HFA INHALATION AEROSOL 100MCG

June 24, 2011

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

AEROSOL, METERED

RESPIRATORY (INHALATION)

Medical Information

R03AC02

salbutamol

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

Salbutamol Sulphate 120mcg equivalent Salbutamol

100mcg/actuation

Salbutamol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZMASOL HFA INHALATION AEROSOL 100MCG - HSA Approval | MedPath